BETHESDA, Md. (AP) — BETHESDA, Md. (AP) — Northwest Biotherapeutics Inc. (NWBO) on Wednesday reported a loss of $10.7 million in its first quarter.
The Bethesda, Maryland-based company said it had a loss of 1 cent per share.
The cancer drug developer posted revenue of $880,000 in the period.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NWBO at https://www.zacks.com/ap/NWBO
© 2023 . All rights reserved. This website is not intended for users located within the European Economic Area.